CSO Forum: The Promise of Immunotherapy

CSO Forum: The Promise of Immunotherapy

Immunotherapies are saving lives. Still, they are only effective for 25% of cancer patients. Dana-Farber is dedicated to changing that statistic, leading novel approaches to harness the body’s immune system to destroy cancer cells.

Watch as Dana-Farber’s Chief Scientific Officer, Kevin Haigis, PhD, leads a discussion with three immunology experts, Judith Agudo, PhD, Stephanie Dougan, PhD, and Evanna Mills, PhD, discussing how they are using basic science to tackle some of immunology’s most complex challenges, particularly in breast cancer, colon cancer, melanoma, and pancreatic cancer. The panelists also highlight the importance of collaboration, mentorship, and empowering women scientists in continuing to move this work forward.

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.
There has been an issue submitting your request. Please try again.

Sign up to receive emails from Dana-Farber and the Jimmy Fund.

   Please leave this field empty